Oracle's Bargain Price Tempts, But Financing and Conversion Risks Keep It a Speculative Buy
Read source articleWhat happened
Oracle shares have dropped to around $104, a level the Seeking Alpha article labels a bargain, citing $664B backlog and 121% cloud infrastructure revenue growth. However, the deep value report flags that only 13% of remaining performance obligations convert within 12 months, while capex, lease commitments, and negative free cash flow continue to strain the balance sheet. The company has already fully utilized a $20 billion ATM offering, raising $19.9B in Q1 FY2027, and faces potential credit downgrade below BBB- if leverage deteriorates further. The article's $188 12-month target assumes successful execution and multiple expansion, but the deep value report's bull case is only $160, with a bear case of $95, suggesting the article may be overly optimistic. At $104, the stock sits below the deep value report's attractive entry of $115, but until we see faster RPO conversion and moderating capital intensity, the risk/reward remains uncertain.
Implication
Longer term, Oracle's ability to convert its $664B backlog into revenue while managing heavy capex and lease commitments will determine whether this is a value trap or a genuine bargain; if execution improves within the next two quarters (RPO conversion above 15%, positive FCF trajectory, no further dilution), the stock could re-rate toward the $160 bull case; conversely, additional project delays, a credit downgrade, or weak customer prepayments could push shares toward the $95 bear case; given the balance sheet leverage, even at $104 the margin of safety is not substantial, so investors should demand evidence of improved fundamentals before sizing up; the article's $188 target appears to extrapolate optimistic assumptions and should be heavily discounted.
Thesis delta
The new article's lower price point shifts the risk/reward from a clear WAIT toward a potential speculative accumulation for those with higher risk tolerance, as $104 is below the prior attractive entry of $115; however, the core thesis concerns (slow RPO conversion, negative FCF, dilution, and downgrade risk) remain unchanged, and the article provides no new evidence that these will resolve; therefore, the thesis shifts only modestly: from WAIT to a tentative BUY on further weakness or confirmation of execution, but not a high-conviction BUY at current levels.
Confidence
Medium